Results 241 to 250 of about 1,805,326 (286)

Deviations from additivity in APOE4-mediated late-onset Alzheimer's disease risk across races and ethnicities. [PDF]

open access: yesHum Genet
Durodoye RO   +17 more
europepmc   +1 more source

Multi‐omics and low‐input proteomics profiling reveals dynamic regulation driving pluripotency initiation in early mouse embryos

open access: yesFEBS Open Bio, EarlyView.
Mouse pre‐implantation development involves a transition from totipotency to pluripotency. Integrating transcriptomics, epigenetic profiling, low‐input proteomics and functional assays, we show that eight‐cell embryos retain residual totipotency features, whereas cytoskeletal remodeling regulated by the ubiquitin‐proteasome system drives progression ...
Wanqiong Li   +8 more
wiley   +1 more source

Evaluating ChatGPT's Ability to Answer Common Parent Questions on Avascular Necrosis in Children. [PDF]

open access: yesHSS J
Smith GB   +7 more
europepmc   +1 more source

Differential regulation of ZFAS1 splice variants by endoplasmic reticulum stress in hepatocyte cell lines

open access: yesFEBS Open Bio, EarlyView.
ZFAS1 is a lncRNA promoting cell proliferation and migration, exhibiting high expression in various cancers. It is conserved, widely expressed, and produces multiple splice variants with unclear roles. We identified several splice variants in hepatocyte models, and found that inhibiting or suppressing regulators of the unfolded protein response (PERK ...
Sébastien Soubeyrand   +2 more
wiley   +1 more source

Bispecific antibodies and CAR T cells targeting a TP53 mutation-associated neoantigen show discordant affinity requirements. [PDF]

open access: yesJ Clin Invest
DiNapoli SR   +29 more
europepmc   +1 more source

Novel trinucleotide mRNA capping reagents: improved synthetic route and efficient cotranscriptional incorporation in mRNA. [PDF]

open access: yesRNA
Xu C   +14 more
europepmc   +1 more source

PD-L1 expression on circulating tumor cells for predicting clinical outcomes in patients with hepatocellular carcinoma receiving PD-(L)1 blockade and targeted therapy. [PDF]

open access: yesJ Immunother Cancer
Gong C   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy